HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 22.27

Change

+0.24 (+1.11)%

Market Cap

USD 0.04B

Volume

4.77K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.54 (+1.16%)

USD 62.43B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.10 (+0.41%)

USD 12.61B
WRD:PA HSBC ETFs Public Limited Compa..

+0.22 (+0.65%)

USD 10.15B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.13 (+0.47%)

USD 8.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+4.25 (+0.98%)

USD 7.87B
HHH:PA HSBC ETFs Public Limited Compa..

+0.37 (+0.72%)

USD 7.00B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.15 (+0.65%)

USD 6.81B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.12 (+0.67%)

USD 6.39B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+2.26 (+0.62%)

USD 4.94B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.76 (+0.52%)

USD 4.74B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.58% 56% F 67% D+
Dividend Return N/A 41% F 68% D+
Total Return N/A 44% F 71% C-
Trailing 12 Months  
Capital Gain 15.41% 47% F 64% D
Dividend Return N/A 66% D+ 44% F
Total Return N/A 19% F 99% N/A
Trailing 5 Years  
Capital Gain 40.14% 52% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.14% 49% F 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 9.81% 63% D 64% D
Dividend Return N/A 35% F 47% F
Total Return N/A 61% D- 31% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 75% C 81% B-
Risk Adjusted Return N/A 68% D+ 95% A
Market Capitalization 0.04B 12% F 30% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.